Literature DB >> 35371929

Clinical and MRI features about two types of silent cerebral small-vessel disease in type-2 diabetes mellitus: a retrospective cross-sectional study in a tertiary hospital.

Dan-Qiong Wang1,2, Lei Wang2, Xiao-Shuang Xia1, Miao-Miao Wei1, Xiao-Lin Tian1, Liang-Fang Wang3, Xin Li1.   

Abstract

Background: The present study aimed to evaluate the frequency of silent cerebral small-vessel disease, especially lacunes and white matter hyperintensities, in patients with or without the impaired glucose tolerance (IGT) and type-2 diabetes mellitus, and to characterize the diabetes-correlated factors related to silent cerebral small-vessel disease.
Methods: This is a retrospective cross-sectional study. Totally 698 patients were included in this study, from January 2014 to December 2019, among which 270 patients were included in the diabetes mellitus group, 106 patients were included in the IGT group, and 322 patients were included in the Control group. All patients underwent magnetic resonance imaging to investigate the silent cerebral small-vessel disease: the lacunes and the white matter hyperintensities. All the baseline information and diabetes-related factors, such as glycated hemoglobin level, insulin usage, etc., were collected. Then correlation analysis and regression analysis were used to explore the correlation between diabetes with related risk factors and silent cerebral small-vessel disease.
Results: Lacunes and white matter hyperintensities were more common in the diabetes mellitus group than in the IGT group and the Control group, with an occurrence of lacunes of 83.3% vs. 70.8% vs. 70.4% (P=0.003), respectively, and an occurrence of white matter hyperintensities of 41.1% vs. 24.5% vs. 31.1% (P=0.003), respectively. The occurrence of lacunes was correlated with the duration of diabetes mellitus [odds ratio (OR) =1.483, 95% confidence interval (CI): 1.082-2.031, P=0.009] and the age (OR =1.141, 95% CI: 1.102-1.180, P<0.001), while white matter hyperintensities were independently correlated only with the age (OR =1.124, 95% CI: 1.094-1.155, P<0.001). Conclusions: Lacunes and white matter hyperintensities, are more common in the diabetes mellitus patients than in the IGT patients or in the other patients. The occurrence of lacunes was correlated with the duration of diabetes mellitus and the age, while the occurrence of white matter hyperintensities was independently correlated with the age. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Cerebral small-vessel disease (CSVD); lacunes; magnetic resonance imaging (MRI); type-2 diabetes mellitus; white matter hyperintensities (WHMs)

Year:  2022        PMID: 35371929      PMCID: PMC8923852          DOI: 10.21037/qims-21-786

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  49 in total

Review 1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

Review 2.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

3.  Nonfasting Glucose and Incident Stroke and Its Types - The Circulatory Risk in Communities Study (CIRCS).

Authors:  Hironori Imano; Hiroyasu Iso; Akihiko Kitamura; Kazumasa Yamagishi; Mina Hayama-Terada; Isao Muraki; Takeo Okada; Mitsumasa Umesawa; Tetsuya Ohira; Tomoko Sankai; Renzhe Cui; Takeshi Tanigawa; Masahiko Kiyama
Journal:  Circ J       Date:  2018-02-14       Impact factor: 2.993

4.  Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.

Authors:  Keith A Hawkins; Nazli Emadi; Godfrey D Pearlson; Anderson M Winkler; Beth Taylor; Latha Dulipsingh; Diana King; Brian Pittman; Karen Blank
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

5.  Atherosclerosis in intracranial or extracranial vessels in diabetic patients and the association with stroke subtype.

Authors:  Li-Ming Wei; Yue-Qi Zhu; Yu-Qian Bao; Hai-Tao Lu; Pei-Lei Zhang; Yu-Wu Zhao; Mei Li; Jun-Gong Zhao
Journal:  Quant Imaging Med Surg       Date:  2019-06

6.  Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics.

Authors:  Adam de Havenon; Jennifer J Majersik; David L Tirschwell; J Scott McNally; Gregory Stoddard; Natalia S Rost
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910

7.  Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study.

Authors:  Michelle R Caunca; Victor Del Brutto; Hannah Gardener; Nirav Shah; Nelly Dequatre-Ponchelle; Ying Kuen Cheung; Mitchell S V Elkind; Truman R Brown; Charlotte Cordonnier; Ralph L Sacco; Clinton B Wright
Journal:  J Am Heart Assoc       Date:  2016-09-16       Impact factor: 5.501

Review 8.  Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities.

Authors:  Toshitaka Umemura; Takahiko Kawamura; Nigishi Hotta
Journal:  J Diabetes Investig       Date:  2016-08-03       Impact factor: 4.232

9.  Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review.

Authors:  Dan-Qiong Wang; Lei Wang; Miao-Miao Wei; Xiao-Shuang Xia; Xiao-Lin Tian; Xiao-Hong Cui; Xin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-21       Impact factor: 5.555

10.  Standards of care for type 2 diabetes in China.

Authors:  Jianping Weng; Linong Ji; Weiping Jia; Juming Lu; Zhiguang Zhou; Dajin Zou; Dalong Zhu; Liming Chen; Li Chen; Lixin Guo; Xiaohui Guo; Qiuhe Ji; Qifu Li; Xiaoying Li; Jing Liu; Xingwu Ran; Zhongyan Shan; Lixin Shi; Guangyao Song; Liyong Yang; Yuzhi Yang; Wenying Yang
Journal:  Diabetes Metab Res Rev       Date:  2016-07       Impact factor: 4.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.